The Laboratory Industry’s Next Competitor May Be the Company on Your Patient’s Wrist
The industry’s next major competitor may never build another national laboratory network or employ thousands…
The Laboratory Industry’s Next Competitor May Be the Company on Your Patient’s Wrist
The industry’s next major competitor may never build another national laboratory network or employ thousands of phlebotomists. It may simply own the device that notices something first. The post The Laboratory Industry’s Next Competitor May Be the Company on Your Patient’s Wrist appeared first on MedCity News.
When a Gun Owner Shows Early Signs of Dementia
If you or someone you know may be experiencing a mental health crisis, contact the 988 Suicide & Crisis Lifeline by dialing or texting “988.” He was 72, a retired health administrator who lived alone near Seattle. Laura Prater, a firearms researcher at Ohio State, was interviewing him via Zoom. She’d administered a questionnaire that…
The Ultimate Adulting Task: Signing Up for Health Insurance
(Maria Fabrizio for WPLN and KFF Health News) Not many 22-year-olds share DJ Mikunda’s enthusiasm for health insurance coverage. “You know what sounds like a good Friday night? It’s looking at health insurance,” he joked. But Mikunda has a reason to be eager. He has gone without coverage since he left home and started working…
Nebraska Rushed Medicaid Work Rules. Then a Cancer Patient Was Told He’d Lost Coverage.
Eli McCreary of Omaha, Nebraska, said he had recently been diagnosed with kidney cancer when he got a call from a local hospital run by CHI Health. He said he was informed that he wasn’t insured anymore under Medicaid — and that the hospital would cancel his appointments unless he paid out-of-pocket. McCreary, who was…
The Drug Enterprise in the Age of AI
AI is speeding up the search for new medicines. Can it make the discoveries themselves? Few people are better placed to answer than Dr. Elias Zerhouni. He ran the National Institutes of Health, then global R&D at Sanofi. He co-founded ModeX Therapeutics, which uses machine learning to design antibodies that don’t exist in nature, and…
Science FTW
By KIM BELLARD Science won. At least, that’s one of the takeaways from last week’s midterm elections. If you were one of the 124 million Americans who voted, you probably already know that there was a Blue Wave, with resounding Democrat victories across the country, even in historically red areas. Georgia not only reelected its…
Amy Bucher, Lirio Health
Lirio Health is an interesting under-the-radar company, which works with plans, providers and others to try to influence the behavior of their members and patients. Of course, everybody wants to change the behavior of human beings, and it’s been proven over the years to be very hard. Lirio probably has more PhDs per square foot…
Startup Supporting Caregivers Raises $3.5M in Seed Funding
Avanlee Care’s seed round was led by BEA Venture Fund, with participation from existing investors, including Board Chair Esther Dyson, Chrysalis Ventures and FairBridge VC. The post Startup Supporting Caregivers Raises $3.5M in Seed Funding appeared first on MedCity News.
Digital Health’s GLP-1 Strategy: “You Didn’t Come for the Drug. You Came for Health”
In a panel discussion, executives from Noom, Omada, Virta and Twin Health discussed how they are going beyond the pill in their GLP-1 strategy and responded to a question about whether they will exist two-to-three years from now. The post Digital Health’s GLP-1 Strategy: “You Didn’t Come for the Drug. You Came for Health” appeared…
Argenx Adds Oral Peptides to Its Immunology Strategy With $550M UNP Acquisition
Argenx’s Unnatural Products acquisition brings a macrocyclic peptides discovery platform for developing oral peptide drugs. The deal brings a new modality to Argenx, whose immunology R&D had focused on antibodies. The post Argenx Adds Oral Peptides to Its Immunology Strategy With $550M UNP Acquisition appeared first on MedCity News.
